Bertin M, Muller A, Bertrand X, Cornette C, Thouverez M, Talon D
Service d'Hygiène Hospitalière et d'Epidémiologie Moléculaire, CHU Jean Minjoz, 25030 Besançon, France.
Eur J Clin Microbiol Infect Dis. 2004 May;23(5):375-9. doi: 10.1007/s10096-004-1129-1. Epub 2004 Apr 27.
To investigate the relationship between glycopeptide use and decreased susceptibility to teicoplanin in coagulase-negative staphylococci (CNS) isolates, data on teicoplanin susceptibility and glycopeptide use from existing microbiology laboratory and pharmacy databases were collected for the period between July 2000 and March 2001. Pooled data for the entire study period were first used to analyse associations. Univariate analysis showed that the incidence of CNS with decreased susceptibility to teicoplanin was significantly correlated with the use of glycopetides, particularly with vancomycin use. This association was confirmed by multivariate analysis. This study suggests that variations in antimicrobial resistance are related to variations in antimicrobial use in the model of CNS with decreased susceptibility to teicoplanin, thus confirming the usefulness of restricting antimicrobial prescribing as a means of controlling resistance.
为了研究凝固酶阴性葡萄球菌(CNS)分离株中糖肽类药物的使用与替考拉宁敏感性降低之间的关系,收集了2000年7月至2001年3月期间现有微生物学实验室和药房数据库中有关替考拉宁敏感性和糖肽类药物使用的数据。整个研究期间的汇总数据首先用于分析相关性。单因素分析表明,对替考拉宁敏感性降低的CNS发生率与糖肽类药物的使用显著相关,尤其是与万古霉素的使用相关。多因素分析证实了这种关联。本研究表明,在对替考拉宁敏感性降低的CNS模型中,抗菌药物耐药性的变化与抗菌药物使用的变化有关,从而证实了限制抗菌药物处方作为控制耐药性手段的有效性。